Download our appsđź”’ SSL Verified
Live Data Status: |E-commerce & Retail
Welcome to the detailed analysis for pharmatimes.com. This domain is officially recognized as PharmaTimes | in-depth news, features and insights for the pharmaceutical and healthcare sectors. According to their official web presence, their primary focus is: "Detailed SEO and authority metrics for pharmatimes.com. Pharmatimes currently holds an estimated domain authority score of 84/100 in the .COM namespace based on our global index mapping.".
Table of Contents
- ↓ Share the bill
- ↓ R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia
- ↓ Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million
- ↓ Nouscom to present re‑treatment data in Lynch Syndrome at ESMO 2026
- ↓ ViiV Healthcare to unveil new HIV treatment data at AIDS 2026
- ↓ Jasper Therapeutics merges with Kira Pharmaceuticals
- ↓ Top Alternatives to pharmatimes.com
- Tech Stack
- WordPressCloudflare
- Link Profile
- Internal Pages: 92Outbound Links: 8
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$15,642
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- pharmatimes.comTaken
- pharmatimes.netTaken
- pharmatimes.orgTaken
- pharmatimes.ioAvailable
- pharmatimes.coAvailable
- pharmatimes.aiAvailable
Official Contact & Profiles
Content Snippets from pharmatimes.com
"What the NHS Modernisation Bill means for the life science..."
"First patient randomised as study advances novel pan phosphate transporter inhibitor"
"Move sharpens Mission’s focus on CNS pipeline as renal specialist takes AKI asset forward"
"Long‑term follow‑up reinforces momentum toward registration‑enabling trial"
Key Topics & Focus Areas for pharmatimes.com:
Share the bill
R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia
Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million
Nouscom to present re‑treatment data in Lynch Syndrome at ESMO 2026
ViiV Healthcare to unveil new HIV treatment data at AIDS 2026
Jasper Therapeutics merges with Kira Pharmaceuticals
By comparing pharmatimes.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to pharmatimes.com.
Frequently Asked Questions
Is pharmatimes.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of pharmatimes.com?
As of July 22, 2026, pharmatimes.com holds an estimated domain authority score of 79/100 based on our VisitRank tracking algorithms.
What are the top alternatives to pharmatimes.com?
You can find the best alternatives and similar sites to pharmatimes.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for pharmatimes.com:
pahrmatimes.comphrmatimes.comphharmatimes.comphermatimes.compharmetimes.compharmatomes.compharmatimas.compgarmatimes.compyarmatimes.com